(AP) — Two officials familiar with the matter say Canada’s National Advisory Committee on Immunization is recommending a pause on AstraZeneca COVID-19 vaccinations for people under 55 for safety reasons.
The provinces of Quebec, Manitoba and Prince Edward Island announced a suspension of the use of the Oxford-AstraZeneca for people under the age of 55 following concerns it may be linked to rare blood clots.
Quebec said in a news release that the decision was taken in conjunction with the Public Health Agency of Canada as well as provincial and federal vaccine advisory committees.
